Connect Biopharma Holdings Limited

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTB and other ETFs, options, and stocks.

About CNTB

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. 

CEO
Barry D. Quart
CEOBarry D. Quart
Employees
62
Employees62
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2015
Founded2015
Employees
62
Employees62

CNTB Key Statistics

Market cap
83.03M
Market cap83.03M
Price-Earnings ratio
-5.27
Price-Earnings ratio-5.27
Dividend yield
Dividend yield
Average volume
88.45K
Average volume88.45K
High today
$1.51
High today$1.51
Low today
$1.40
Low today$1.40
Open price
$1.49
Open price$1.49
Volume
37.88K
Volume37.88K
52 Week high
$2.86
52 Week high$2.86
52 Week low
$0.51
52 Week low$0.51

People also own

Based on the portfolios of people who own CNTB. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.